Chembio Diagnostic Systems, Inc.

Update: We have submitted our EUA Application for the New DPP SARS-CoV-2 IgM/IgG Test System. Read more here. https://hubs.ly/H0v-fCq0

We are excited to announce that we are planning to Seek EUA Approval from the FDA for Our Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System. Learn more here. https://hubs.ly/H0sLHr10

We are excited to announce our partnership with BARDA to develop a rapid point-of-care diagnostic test for the detection of SARS-CoV-2 in respiratory specimens. Learn more here.

We have received FDA 510(k) Clearance for our DPP Zika IgM System. Learn more here. https://hubs.ly/H0rldkq0

Check out our DPP COVID-19 Product Website Page to learn more about how you can detect COVID-19 Antibodies with Fingerstick Samples. Request more information here: https://hubs.ly/H0qYsw_0

We Would Like To Announce Our US Distribution Agreement to Expand Reach of Our DPP COVID-19 Serological Test with Thermo Fisher Scientific’s Healthcare Channel. Learn more here: https://hubs.ly/H0qCQF50

We Have Received CE Marking for Our DPP COVID-19 System for IgM and IgG Antibodies. Read more here. https://hubs.ly/H0q7JZk0

We Are Excited to Announce That We Have Received Emergency Use Authorization for our DPP COVID-19 System for IgG and IgM Antibodies. Learn more here https://hubs.ly/H0pw8Gk0 Feel free to contact us at https://hubs.ly/H0pw3cy0

April 12-18th is STD Awareness Week. Remember to get yourself tested. Thumbs up if you like! Feel free to tag your friends #STDWeek

We are excited to announce that we have collaborated with Stony Brook Medicine to Identify Recovered Coronavirus Patients. Read more here. https://hubs.ly/H0pmXs50